Navigation Links
New Approach to Early Detection of Ovarian Cancer

Despite advances in surgery and chemotherapy, ovarian cancer is still the most lethal form of gynecologic cancer and the fourth leading cause of cancer death among women// in the United States; claiming 16,210 lives in 2005.

Survival rates for ovarian cancer have remained stubbornly low because symptoms are often vague and mimic other conditions, and the lack of a cost-effective, reliable test to diagnose this “silent killer” early, when it is most curable. A test is urgently needed that would rival the positive impact on survival that the Pap smear and mammography have had on cancers of the cervix and breast, respectively.

The statistics tell the story. Currently, three of every four women have advanced stage ovarian cancer when they are diagnosed, and only 25 percent of these women survive for five years. In contrast, the one woman in four diagnosed with early stage disease has a five-year survival rate exceeding 90 percent.

Now, innovative research at Roswell Park Cancer Institute and the University at Buffalo has produced compelling evidence that a simple blood test for early ovarian cancer screening might be developed sooner rather than later.

Scientists at these institutions have used sophisticated computer-modeling programs to interpret data from nuclear magnetic resonance (NMR) analyses of blood samples and produce cellular profiles that show the identities, structures and proportions of metabolites (metabonomics).

This NMR-based metabonomics approach has identified characteristics, known as biomarkers, in blood samples that can leave a “biomolecular signature” that distinguishes women with early stage ovarian cancer from healthy women. Scientists believe that these biomarkers could be developed into a screening test for ovarian cancer.

However, before this simple blood test can be developed, researchers will use the same approach to hone in on the specific metabolite (or metabolites) re sponsible for differences between healthy women and cancer patients, and make early diagnosis of ovarian cancer possible. These metabolites also could be targets for therapy.

Scientists believe that this NMR-based metabonomics approach will not only benefit thousands of women each year, but have practical implications in other types of cancer as well.

(Source: Newswis)
'"/>




Related medicine news :

1. New Dietary Approach To Manage Kidney Stones
2. Approaching through Telemedicine benefits patients
3. Gel Offers A More Targeted Approach
4. New Cost Effective Approach To Promote Sun Protection
5. Treatment Of Brain Aneurysms By A New Non-Surgical Approach
6. A New Approach In Treatment Neurogenic Detrusor Overactivity In Children
7. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
8. Lazy Eye Can Be Effectively Treated By New Approach
9. Novel Approach to Identify Protein Links with Genetic Disorder
10. NHS To Be Reformed By Using A Hybrid Approach
11. Two-In One Approach To Prevent Incontinence After Prolapse Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... Lutz, FL (PRWEB) , ... April 25, 2017 , ... ... transform their smiles by using Invisalign® in Lutz, FL. With the help ... oral health and aesthetics with fewer potential complications, more discretion and less pain. ...
(Date:4/25/2017)... ... 25, 2017 , ... As Spring reignites vigilance against Zika ... to Zika virus during pregnancy, as well as other prenatal exposures like cocaine, ... , The Teratology Society is an international and multidisciplinary group of ...
(Date:4/25/2017)... ... ... B. Chaudhary, MD is committed to providing the highest quality of spine care to all ... care with all my patients to alleviate possible future issues. I am pleased to have ... office and my trained staff will assist you in any way possible.” , Dr. Saad ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in ... a special report in the May issue of Consumer Reports focused on heart health. ... for results achieved during and after coronary bypass and aortic valve replacement procedures. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 ... an immune response in pets such as canine, ... are of various types such as Attenuated Live ... Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live ... virus or bacteria, which have been weakend under ...
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology: